Trodelvy OverviewSacituzumab govitecan, sold under the brand name Trodelvy, is a Trop-2-directed antibody and topoisomerase inhibitor drug conjugate for the treatment of adults with triple-negative breast cancer (TNBC) that has spread to other parts of the body and have received at least two prior therapies. The most common side effects are nausea, neutropenia, diarrhea, fatigue, anemia, vomiting, alopecia (hair loss), constipation, decreased appetite, rash and abdominal ...
Read more Trodelvy Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sacituzumab_govitecan
Recent Trodelvy Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 180mg
NDC Database Records for Trodelvy: (1 result)Sorted by National Drug Code
- 55135-132 Trodelvy 180 mg Intravenous Powder, for Solution by Immunomedics, Inc.